We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ADVANTECH SERVICE-IOT CO., LTD. TAIWAN BRAN

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
14 Jul 2020 - 14 Jul 2020
Virtual Venue
15 Jul 2020 - 19 Jul 2020
Virtual Venue

New Imaging Device Identifies Parathyroid Glands During Surgery

By HospiMedica International staff writers
Posted on 27 Nov 2019
Print article
Image: The Fluobeam LX parathyroid imaging device (Photo courtesy of Fluoptics)
Image: The Fluobeam LX parathyroid imaging device (Photo courtesy of Fluoptics)
A new device that uses autofluorescence imaging to identify the parathyroid glands reduces the incidence of post-thyroidectomy hypocalcemia.

The Fluoptics (Grenoble, France) Fluobeam LX is an imaging device exclusively dedicated to thyroid and parathyroid surgery that detects the parathyroid gland by autofluorescence in the near-infrared (nIR) light band, with the aid of an optimized real-time display, a high depth of field, and compatibility with ambient operating room lights. Handheld and easily manipulated to cover the surgical field, Fluobeam LX offers an optimized ergonomics with a joystick that simplifies the navigation and selection of the software functionalities, directly by the surgeon.

The system’s camera significantly reduced sensitivity to ambient light, allowing real-time visualization of the parathyroid glands in autofluorescence, even with the operating lights switched on (without direct illumination of the surgical field). The camera also provides a high frame rate (25 frames per second) and a high depth of field (over five cm). When combined with proprietary Fluosoft imaging software, the Fluobeam LX allows surgeons to work in optimized conditions, with easy interpretation of images and manipulation of the device.

“For some patients with parathyroid disease, treatment may mean a surgical procedure,” said Binita Ashar, MD, director of the division of surgical devices at the US Food and Drug Administration (FDA; Silver Spring, MD, USA) Center for Devices and Radiological Health (CDRH). “Real-time identification of parathyroid tissue during surgery can provide surgeons with valuable information to help preserve healthy tissue or to remove diseased tissue.”

Unintentional injury to the parathyroid glands during thyroidectomy can impede the secretion of parathyroid hormone (PTH), triggering temporary hypocalcaemia, a decrease in calcium levels in the blood, which needs to be treated by oral calcium calcitriol for an unknown duration. The treatment can also lead to additional complications such as skin necrosis (in case of calcium gluconate extravasation), constipation, and extended hospitalization.

Related Links:
Fluoptics
US Food and Drug Administration



Print article

Channels

Business

view channel
Illustration

Omnia Health Live Unites Global Healthcare Community Through New Virtual Experience

Omnia Health Live, a virtual healthcare event, has brought the global healthcare community together on a scale never seen before through a new experience delivered entirely online. The virtual healthcare... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.